Abstract: Provided are a binding band assembly for a headset and a headset. The binding band assembly includes: a housing in which a rotatable gear is provided; a first binding band and a second binding band each provided with a rack meshed with the gear to drive the first binding band and the second binding band to move towards or away from each other when the gear rotates; a transmission member provided in the housing and fixedly connected to the gear; and a rotation control member provided on the housing and having a toggle portion, a rolling member being provided between the toggle portion and the transmission member, and the toggle portion being configured to drive, by pushing the rolling member to roll, the transmission member to rotate.

Abstract: A head-mounted display device is provided, which includes: a housing; a main circuit board; at least two camera components; at least two flexible connecting members respectively connected in correspondence with the at least two camera components; the main circuit board and the at least two camera components are provided in the housing; each camera component is electrically connected to the main circuit board through a corresponding flexible connecting member; at least two layers of the flexible connecting members are stacked and insulated from each other; the at least two flexible connecting members are in a bent state.

Abstract: An adjusting apparatus for a head-mounted electronic device and a head-mounted electronic device having the same. The adjusting apparatus comprises a base assembly, a strap retracting and releasing assembly, and a cable retracting and releasing assembly, wherein the strap retracting and releasing assembly comprises a strap and a telescopic mechanism that cooperates with the strap to drive the strap to move telescopically relative to the base, wherein the cable retracting and releasing assembly comprises a cable and a retracting and releasing mechanism that is provided on the base and comprises a rotary plate and an elastic member, the rotary plate being rotatable relative to the base and cooperating with the cable, and the elastic member applying an action force to the rotary plate to retract the cable.

Abstract: The present application relates to the field of camera technology, and particularly relates to a camera module and an electronic device. The camera module comprises a base assembly; a lens assembly axially movably disposed on the base assembly; a temperature drift compensation assembly mounted to the base assembly, the temperature drift compensation assembly configured to be deformable to drive axial movement of the lens assembly relative to the base assembly; a control assembly electrically connected to the temperature drift compensation assembly, the control assembly configured to generate a control signal based on a temperature within the camera module, the temperature drift compensation assembly able to deform in response to the control signal.

Abstract: Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.

Abstract: A strap adjustment apparatus of a head-mounted electronic device, and a head-mounted electronic device. The strap adjustment apparatus comprises: a strap assembly wherein the strap assembly comprises a strap and a driving gear, the strap comprises a rack portion, and the driving gear is meshed with the rack portion to drive the strap to move by means of the rotation of the driving gear; a knob assembly, wherein the knob assembly comprises a knob and a self-locking mechanism, and the self-locking mechanism cooperates with the knob to limit the rotation direction of the knob; and an elastic reset element, wherein the elastic reset element and the knob are linked to each other so as to switch between a compressed state and a reset state. Therefore, the length of the strap assembly can be adjusted, and the strap adjustment apparatus is matched with a wearer.

Abstract: The present disclosure provides a head-mounted virtual reality apparatus. The head-mounted virtual reality apparatus includes a first strap and a second strap, a second end of the first strap and a second end of the second strap are both laminated within a housing, a portion of the wire is gathered on a first side of the housing, and the second end of the second strap has an open slot that forms a second chute, the open slot is opposite to the wire and the open slot is in a direction consistent with a direction of movement of the second strap.

Abstract: Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.

Abstract: The present disclosure provides a head-mounted virtual reality apparatus. The head-mounted virtual reality apparatus includes a first strap and a second strap, a second end of the first strap and a second end of the second strap are both laminated within a housing, a portion of the wire is gathered on a first side of the housing, and the second end of the second strap has an open slot that forms a second chute, the open slot is opposite to the wire and the open slot is in a direction consistent with a direction of movement of the second strap.

Abstract: Provided are a binding band assembly for a headset and a headset. The binding band assembly includes: a housing in which a rotatable gear is provided; a first binding band and a second binding band each provided with a rack meshed with the gear to drive the first binding band and the second binding band to move towards or away from each other when the gear rotates; a transmission member provided in the housing and fixedly connected to the gear; and a rotation control member provided on the housing and having a toggle portion, a rolling member being provided between the toggle portion and the transmission member, and the toggle portion being configured to drive, by pushing the rolling member to roll, the transmission member to rotate.

Abstract: An interaction method for game live-streaming includes displaying, on a terminal device, a first game interface of a game application, and, in response to a first trigger operation associated with a live-streaming screen of the game application, generating and displaying a second game interface and a live-streaming screen of the game application. Generating and displaying the second game interface and the live-streaming screen includes creating a picture-in-picture view and adding the picture-in-picture view to a first region of the second game interface, and displaying, on the terminal device, the live-streaming screen in the picture-in-picture view in the first region of the second game interface.

Abstract: Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.

Abstract: Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.

Abstract: Disclosed are compositions and methods for treating dystrophinopathies. Compositions include modified dystrophin polynucleotides that encode modified dystrophin proteins having modified hinge 1 (H1) and/or hinge 4 (H4). Also disclosed are methods for treating dystrophinopathies by administering compositions encoding modified dystrophin proteins having modified hinge 1 (H1) and/or modified hinge 4 (H4).

Abstract: According to the embodiments described herein, a series of biological materials for treatment/therapy of DMD and/or BMD through the recovery of sarcolemmal nNOS is provided. The biological material comprises the complete dystrophin repeats R16 and R17 or certain domains, sections, or fragments of the dystrophin repeats R16 and R17. In some aspects, such domains, sections, or fragments may be selected from sequence motifs including dystrophin R17 ?1 helix, ?2 and ?3 helices of both R16 and R17, or a combination thereof.

Abstract: Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.

Abstract: A head mounted device includes a virtual reality helmet, a control section, a transmission line and a head band portion. The head band portion includes a rotatable head band detachably positioned on the virtual reality helmet via a connection mechanism including a catching connection portion and a fixing portion having a main body portion. The catching connection portion is mounted in a counterbore of the rotatable head band and includes a catching fixture, two catching halves, a push button and a first elastic part. A driving portion of the bush button moves upward vertically and drives the action of the two driven portions of two catching halves to open or close two catching portions of the catching halves transversely, and thus perform the connection or detachment with the caught portion on the main body portion of the fixing portion.

Abstract: The present invention provides a head mounted device. Said head mounted device includes a visual reality helmet (1), a control section (2), a transmission line (4) and a head band portion. Said visual reality helmet (1) includes a mask proximate to user's face and a display screen in front of the mask. The control section (2) is connected with the visual reality helmet (1) as a whole via the transmission line (4), in order to control the operation of the head mounted device. The head band portion is intended to mount this visual reality helmet (1) onto the head of a user. By providing a control section (2) to be connected with the visual reality helmet (1), the head mounted device disclosed herein does not need to connect with other peripheral devices and thus enhance the portability and the compatibility thereof.

Abstract: According to the embodiments described herein, a series of biological materials for treatment/therapy of DMD and/or BMD through the recovery of sarcolemmal nNOS is provided. The biological material comprises the complete dystrophin repeats R16 and R17 or certain domains, sections, or fragments of the dystrophin repeats R16 and R17. In some aspects, such domains, sections, or fragments may be selected from sequence motifs including dystrophin R17 ?1 helix, ?2 and ?3 helices of both R16 and R17, or a combination thereof.

Abstract: According to the embodiments described herein, a series of biological materials for treatment/therapy of DMD and/or BMD through the recovery of sarcolemmal nNOS is provided. The biological material comprises the complete dystrophin repeats R16 and R17 or certain domains, sections, or fragments of the dystrophin repeats R16 and R17. In some aspects, such domains, sections, or fragments may be selected from sequence motifs including dystrophin R17 ?1 helix, ?2 and ?3 helices of both R16 and R17, or a combination thereof.